There is no evidence that the Atabay acetaminophen formulation increases the risk of illness. 1/7
The Atabay acetaminophen (which is regularly used in Europe) is a lower concentration compared to Canadian acetaminophen products. Because of this, more volume is needed to achieve the same dose. 2/7
Due to the formula’s thickness and the size of the tubes used to administer this medicine in hospitals to children under two in Alberta, a risk was identified for continued use of this medication by Alberta hospitals to children under two years of age. 3/7
However, no children were actually harmed at any time by the medicine. 4/7
Out of an abundance of caution, the use of the Atabay product in neonatal units was discontinued in May 2023, but is still completely safe for oral use or to be administered by health professionals through tubes for children over the age of two. 5/7
Atabay Pharmaceuticals and Fine Chemicals is the sole manufacturer of acetaminophen in the European Union, the Middle East, and North Africa. 6/7
Health Canada approved parol (acetaminophen) from Atabay Pharmaceuticals for use in Alberta hospitals and for sale at pharmacies in 2023. 7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
